Top

Published in:

01-12-2009 | Case Reports

Dramatic complete response in patient with lung adenocarcinoma

Authors: Sara Serrano Solares, Dolores Isla Casado, María Jesús Vidal Losada, María Tobeña Puyal, Ana Isabel Ferrer Pérez, Isabel Pajares

Published in: Clinical and Translational Oncology | Issue 12/2009

Title: Dramatic complete response in patient with lung adenocarcinoma
Authors: Sara Serrano Solares
Dolores Isla Casado
María Jesús Vidal Losada
María Tobeña Puyal
Ana Isabel Ferrer Pérez
Isabel Pajares
Publication date: 01-12-2009
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 12/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-009-0455-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 12/2009

Molecular mechanisms behind the resistance of cisplatin in germ cell tumours

Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study

Clinical practice guidelines for cancer care: what are they for?

Benefit of sperm freezing before radical orchiectomy

Primary breast synovial sarcoma: a rare primary breast neoplasm

Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system

Keynote webinar | Spotlight on antibody–drug conjugates in cancer